Back to all Programs

Register here

Related Materials

Past event

Salvador HIV Clinical Forum 2022

International and Local Guidelines - Focus on Patients' Needs? - Eduardo Sprinz, MD

Is Resistance a Concern When Starting ART? - Monica Gandhi, MD, MPH

Polypharmacy and ART Choice - Esper Kallas, MD, PhD

Choosing the Best Regimen For Older Patients With Comorbidities - Tânia Vergara, MD, PhD

Update on Therapeutic Options for HIV Prevention - Beatriz Grinsztejn, MD, PhD

PrEP On-Demand vs Conventional - Esper Kallas, MD, PhD

Community Perspective on Therapeutic PrEP Options - Alícia Krüger, PharmD, MPH

Clinical Case (focused on prevention) - Gustavo Magalhães, MD, PhD

Role of Nukes and Non-nukes in Current ART - Luis E. Soto-Ramírez, MD

Role of PIs on Current ART - Estevão Portela Nunes, MD, PhD

Clinical Case (focused on starting and switching therapy) - Monica Gomes, MD, PhD

Current and Evolving Therapeutic Options for Highly Treatment Experienced Patients - Monica Gandhi, MD, MPH

Resistance to INSTI: what can we expect? - Ricardo Diaz, MD

Clinical Case (focused on highly treatment experienced patients) - Fabianna Bahia, MD, PhD